This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Wan RY, Kasliwalz M, McKenzie CA, Barrettz NA. Quetiapine in refractory hyperactive and mixed intensive care delirium: a case series. Crit Care. 2011;15(3):R159.WanRYKasliwalzMMcKenzieCABarrettzNAQuetiapine in refractory hyperactive and mixed intensive care delirium: a case seriesCrit Care2011153R15910.1186/cc10294321903321711554Search in Google Scholar
Kasliwal MR, McKenzie C, Barrett NA. Quetiapine in prolonged ICU delirium [abstract 497]. Crit Care. 2010;14(Suppl 1):P497.KasliwalMRMcKenzieCBarrettNAQuetiapine in prolonged ICU delirium [abstract 497]Crit Care201014Suppl 1P49710.1186/cc8729Search in Google Scholar
Hayhurst CJ, Pandharipande PP, Hughes CG. Intensive care unit delirium: a review of diagnosis, prevention and treatment. Anesthesiology. 2016;25(6):1229-41.HayhurstCJPandharipandePPHughesCGIntensive care unit delirium: a review of diagnosis, prevention and treatmentAnesthesiology201625612294110.1097/ALN.0000000000001378511953227748656Search in Google Scholar
Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicentre, randomised, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38:419-27.DevlinJWRobertsRJFongJJEfficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicentre, randomised, double-blind, placebo-controlled pilot studyCrit Care Med2010384192710.1097/CCM.0b013e3181b9e30219915454Search in Google Scholar
Michaud CJ, Bullard HM, Harris SA, Thomas WL. Impact of quetiapine treatment on duration of hypoactive delirium in critically ill adults: a retrospective analysis. Pharmacotherapy. 2015;35(8):731-9.MichaudCJBullardHMHarrisSAThomasWLImpact of quetiapine treatment on duration of hypoactive delirium in critically ill adults: a retrospective analysisPharmacotherapy2015358731910.1002/phar.161926238778Search in Google Scholar
Freudenmann RW, Süssmuth SD, Wolf RC, Stiller P, Schönfeldt-Lecuona C. Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry. 2008;41(3):119-21.FreudenmannRWSüssmuthSDWolfRCStillerPSchönfeldt-LecuonaCRespiratory dysfunction in sleep apnea associated with quetiapinePharmacopsychiatry20084131192110.1055/s-2008-105811118484556Search in Google Scholar
Jabeen S, Pollo SI, Gerber DR. Acute respiratory failure with a single dose of quetiapine fumarate. Ann Pharmacother. 2006;40:559-62.JabeenSPolloSIGerberDRAcute respiratory failure with a single dose of quetiapine fumarateAnn Pharmacother2006405596210.1345/aph.1G49516467251Search in Google Scholar
Cavallazzi R, Saad M and Marik PE. Delirium in the ICU: an overview. Ann of Intensive Care. 2012;2(1):49.CavallazziRSaadMMarikPEDelirium in the ICU: an overviewAnn of Intensive Care2012214910.1186/2110-5820-2-49353989023270646Search in Google Scholar
Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp Inc.; 2019. Available from: http://online.lexi.com.Accessed July 19, 2019.Lexi-drugs online [database on the Internet]Hudson (OH)Lexicomp Inc.;2019Available fromhttp://online.lexi.com.AccessedJuly 19, 2019Search in Google Scholar
DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet. 2001;40(7):509-22.DeVaneCLNemeroffCB.Clinical pharmacokinetics of quetiapine: an atypical antipsychoticClin Pharmacokinet20014075092210.2165/00003088-200140070-0000311510628Search in Google Scholar
Medication guide for Seroquel. U.S Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020639s069lbl.pdf#page=49. Updated 2019. Accessed May 13, 2020.Medication guide for Seroquel. U.S Food and Drug Administrationhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020639s069lbl.pdf#page=49Updated 2019. Accessed May 13, 2020Search in Google Scholar
Ibrahim K, McCarthy CP, McCarthy KJ, et al. Delirium in the cardiac intensive care unit. J Am Heart Assoc. 2018;7(4):e008568. Published Feb 2018. Accessed May 1, 2020.IbrahimKMcCarthyCPMcCarthyKJDelirium in the cardiac intensive care unitJ Am Heart Assoc201874e008568Published Feb 2018. Accessed May 1, 202010.1161/JAHA.118.008568585021129453307Search in Google Scholar
Czekalla J, Beasley CM Jr, Dellva MA, Berg PH, Grundy S. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. J Clin Psychiatry. 2001;62(3):191-8.CzekallaJBeasleyCM JrDellvaMABergPHGrundyS.Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosisJ Clin Psychiatry2001623191810.4088/JCP.v62n0310Search in Google Scholar
Seafim RB, Bozza FA, Soares M, et al. Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care. 2015;30(4):799-807.SeafimRBBozzaFASoaresMPharmacologic prevention and treatment of delirium in intensive care patients: a systematic reviewJ Crit Care201530479980710.1016/j.jcrc.2015.04.005Search in Google Scholar
Balit CR, Isbister GK, Hackett LP, Whyte IM. Quetiapine poisoning: a case series. Ann Emerg Med. 2003;42(6):751-8.BalitCRIsbisterGKHackettLPWhyteIMQuetiapine poisoning: a case seriesAnn Emerg Med2003426751810.1016/S0196-0644(03)00600-0Search in Google Scholar
Wang M, Tsai C, Lin CW, Yeh C, Wang Y, Lin H. Association between antipsychotic agents and risk of acute respiratory failure in patients with chronic obstructive pulmonary disease. JAMA Psychiatry. 2017;74(3):252–260.WangMTsaiCLinCWYehCWangYLinHAssociation between antipsychotic agents and risk of acute respiratory failure in patients with chronic obstructive pulmonary diseaseJAMA Psychiatry201774325226010.1001/jamapsychiatry.2016.379328055066Search in Google Scholar
